India Ministry Says Major Patent Holder Novartis Should Stop Criticizing
This article was originally published in PharmAsia News
India's Commerce and Industry Ministry says more than 80% of drug patents the country grants are to foreign drug makers such as Novartis, which has leveled harsh criticism of the system.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.